ArticleNature communications2020

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

Clara Gómez-Aleza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.